A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

NCT01570582 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

314

Enrollment

OTHER

Sponsor class

Conditions

Fallopian Tube Cancer
Ovarian Cancer
Primary Peritoneal Cancer

Interventions

DRUG: carboplatin and paclitaxel

Sponsor

Korean Gynecologic Oncology Group